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Abstract and Keywords 
Context: Obstructive Sleep Apnea Syndrome it has been recognized as a potential 
independent risk factor for adverse perioperative outcomes and many of them are 
undiagnosed.  
 
Objective(s): STOP-BANG score (snore; tired; observed apnea; arterial pressure; body 
mass index; age; neck circumference and gender) can predict the risk of a patient to 
have Obstructive Sleep Apnea. The aim of this study was, to evaluate the incidence of 
patients with a STOP-BANG ≥3 score and to evaluate its association with postoperative 
adverse respiratory events.  
 
Design: Observational, prospective study.  
 
Setting: Post-Anesthesia Care Unit of a tertiary hospital: Centro Hospitalar São João, 
Porto, Portugal. During the period of 18 June to 12 July 2012. 
 
Patients: 256 patients were admitted and 215 eligible for this study. Written informed 
consent was obtained from all patients. Exclusion criteria were patient refusal, 
incapacity of providing informed consent, a score of <25 in the mini-mental state 
examination test, age under 18 years, foreign nationality, known neuromuscular disease, 
urgent/emergent surgery and cardiac surgery, neurosurgery or other procedures that 
required therapeutic hypothermia.  
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Main outcome measures: All the patients were asked to complete the STOP 
questionnaire and information concerning body mass index, age, neck circumference, 
and gender (BANG) were collected for every patients. 
 
Results: Incidence of patients with a STOP-BANG ≥3 was 51%. These patients were 
older (median age 64 versus 43 years, p<0.001), were more likely to be man (68% 
versus 48%, p<0.001), had a higher body mass index (median 27.7 versus 25.7, 
p<0.001), had a higher ASA physical status (ASA III, IV or V 32% versus 15%, 
p꞊0.004), had higher RCRI scores (8% versus 0% for RCRI>2, p꞊0.002), and showed a 
higher ischemic heart disease (15% versus 0%, p<0.001), congestive heart disease (5% 
versus 0%, p꞊0.017), diabetes with insulin therapy (25% versus 7%, p<0.001), 
hypertension (75% versus 21%, p<0.001), hyperlipidemia (55% versus 13%, p<0.001) 
and chronic pulmonary obstructive disease (12% versus 3%, p꞊0.011). These patients 
had more frequently adverse respiratory events (24% versus 10%, p꞊0.011), had a 
higher incidence of residual neuromuscular blockade (22% versus 15%, p꞊0.021) and 
longer length of stay in the Hospital (median 7 versus 4 days, p=0.005). In the multiple 
logistic regression analysis, chronic pulmonary obstructive disease was considered an 
independent predictor for adverse respiratory events.  
 
Conclusions: Patients with STOP-BANG≥3 score had an important incidence among 
patients scheduled to surgery in our hospital, had more co-morbidities and were more 
prone to postoperative complications.   
 
Key words: Obstructive sleep apnea, STOP-BANG, surgery.  
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Introduction  
Obstructive Sleep Apnea (OSA) is the most prevalent breathing disorder during sleep 
(1), it affects 2-26% of the general population (2) and it has been recognized as a 
potential independent risk factor for an longer length of stay (LOS) in the Hospital and 
for adverse perioperative outcomes namely respiratory and cardiac complications. (3-5) 
OSA is characterized by repeated complete occlusion of the upper airway during sleep 
that last for at least 10 seconds, causing apnoea or hypopnea. (4) 
Increasingly OSA has been associated with some diseases such as: obesity, 
hypertension, dyslipidemia, insulin resistance with development of diabetes, pulmonary 
arterial hypertension, arrhythmias, atrial fibrillation, stroke (3), deep vein thrombosis 
(6), gastroesophageal reflux (7) among others.  
Some studies show that in the general populations at least 80% of patients with OSA are 
undiagnosed. (8, 9) The prevalence of OSA in the surgical population is higher than in 
the general population (3) and 70% of patients undergoing bariatric surgery were found 
to have OSA. (10) 
The gold standard for the diagnosis of OSA, polysomnography (PSG), is impracticable 
as a routine preoperative assessment tool for OSA because it is an expensive and labour 
intensive test. (11) 
Many tools have been proposed for screening patients for OSA such as the Berlin 
questionnaire, the STOP questionnaire and the American Society of Anaesthesiologists 
(ASA) checklist – and the use of these tools improves the likelihood of identifying OSA 
preoperatively. The STOP questionnaire, showed a high sensitivity for detecting OSA 
(when score is >3): 93% and 100% for moderate and severe OSA, respectively; 
however, the specificity at the same cut-off is low: 47% and 37% for moderate and 
severe OSA, respectively, resulting in high false-positive rates. The STOP questionnaire 
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is a scoring model consisting of 8 easily administrated questions starting with the 
acronym STOP-BANG (Appendix) and is scored based on Yes/No answers (scores 
1/0). (12) 
In a study by Chung F et al (13) the authors compared these three scores, and the STOP 
questionnaire showed to be the more accurate in identifying the patients who are more 
likely to develop postoperative complications, like respiratory complications, 
desaturation and severe desaturation. Conversely, these screening techniques have 
limited specificity despite a high sensitivity in the diagnosis of OSA.  
In the immediate postoperative period the most common causes of hypoventilation 
include airway obstruction, the effects of anesthetics, analgesics (eg, opioids), sedatives, 
residual neuromuscular blockade and poorly controlled incisional pain impairing 
respiration. Impaired oxygen exchange in the postoperative period can occur as a result 
of intrapulmonary shunting, pulmonary edema and pulmonary embolus.  
The most common cause of airway obstruction in the Post Anesthesia Care Unit 
(PACU) is pharyngeal laxity due to weakness of the pharyngeal muscles. Other causes 
include laryngospasm, airway edema, hematoma, or a foreign body.  
Loss of pharyngeal motor tone leading to muscular laxity is due to residual 
neuromuscular blockade, residual anesthetic effect, or opioids. Preoperative medical 
conditions such as obstructive sleep apnea can also predispose to airway obstruction in 
the PACU. The diaphragm recovers more quickly from the effects of muscle relaxants 
than the pharyngeal musculature. Residual paralysis of pharyngeal muscles causes the 
base of the tongue and the tissues of the posterior oropharynx to move toward each 
other, obstructing the supraglottic inlet. (14, 15) 
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The aim of this study was, to evaluate the incidence of patients with a STOP-BANG ≥3 
score and to evaluate its association with postoperative adverse respiratory events 
(ARE). 
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Methods 
Subjects and setting 
The study was conducted in the in the Post Anesthesia Care Unit (PACU), of Centro 
Hospitalar São João (CHSJ), Porto, Portugal. Ethical approval (Ethical n.º 127/2012) 
was provided by the Ethical committee of CHSJ (Comissão de Ética para a Saúde do 
Hospital de São João – Chairperson Prof Filipe N.A.S. Almeida). Written informed 
consent was obtained from all patients. 
Centro Hospitalar São João is an 1124-bed tertiary hospital in a major metropolitan area 
that serves 3,000,000 people. This prospective study was conducted in a 12-bed PACU 
over a 4 week period from Monday through Thursday (from18 June to 12 July 2012). 
Every patient admitted to the PACU, during this period of time, who was able to 
provide written informed consent was included in the study. Exclusion criteria were 
patient refusal, incapacity of providing informed consent, a score of <25 in the mini-
mental state examination test (MMSE), age under 18 years, foreign nationality, known 
neuromuscular disease, urgent/emergent surgery and cardiac surgery, neurosurgery or 
other procedures that required therapeutic hypothermia. 
All the patients were asked to complete the STOP questionnaire. Information 
concerning body mass index (BMI) age, neck circumference, and gender (BANG) were 
collected by a research assistant. 
Patients were classified as being at high risk for obstructive sleep apnea (HR-OSA) if 
their STOP-BANG score was 3 or greater and as being at low risk of OSA (LR-OSA) if 
their score was less than 3. 
The anesthesiologist in charge was blinded to patient involvement in the study.  
Anesthesia was provided and monitored according to the criteria of the anesthesiologist 
in charge criteria, but this conduct followed minimum departmental standards. 
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Neuromuscular blocking drugs (NMBD) were used for tracheal intubation, and 
additional boluses were provided, if needed. No written policy exists concerning the use 
of neuromuscular monitoring so this was performed at the discretion of the 
anesthesiologist. To ensure that the anesthesiologist remained blinded to the patients’ 
participation in the study, we did not attempt to observe the use or interpretation of TOF 
intraoperatively. The anesthesiologist was free to decide whether to reverse the 
neuromuscular blockade (NMB) with neostigmine at the conclusion of the surgical 
procedure.  
Usually, the patient was extubated in the operating room and transferred to the PACU. 
Criteria for extubation included sustained head lift or hand grip for more than 5 s, the 
ability to follow simple commands, a stable ventilatory pattern with an acceptable 
arterial oxygen saturation (SpO2) >95%, and a TOF ratio of greater than 0.80. All 
subjects were administered 100% oxygen by a facemask after tracheal extubation. The 
anesthesiologist was free to decide whether to administer oxygen during the time 
between transfer to the cart and admission to the PACU. 
Upon arrival to the PACU oxygen was provided to all subjects by either a nasal cannula 
or face mask. 
A standardized data collection sheet was completed for each patient.  
The recorded patients characteristics were: age, gender, weight, height, BMI, 
benzodiazepines administration before surgery, chronic benzodiazepines use, site of 
surgery (intra-abdominal, musculoskeletal, head and neck), American Society of 
Anesthesiologists physical status (ASA-PS), Revised Cardiac Risk Index (RCRI), 
duration of preoperative fluid fasting, type of anesthesia, duration of surgery, use of 
nitrous oxide, ARE in the PACU, postoperative pain level (VAS score), postoperative 
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nausea and vomiting 6 hours after surgery and 24 hours after surgery, LOS in the PACU 
and in the Hospital.  
The magnitude of the surgical procedure was classified as major (surgery in which body 
cavities or major vessels are exposed to ambient temperature such as major abdominal, 
thoracic, or major vascular, thoracic spine surgery with instrumentation, or hip 
arthroplasty), medium (surgery in which body cavities are exposed to a lesser degree 
such as appendectomy), and minor surgery (superficial surgery).  Major surgery was 
defined as a surgery requiring a hospital stay of 2 or more days. 
 
Clinical risk factors (history of chronic obstructive lung disease, history of ischemic 
heart disease, history of compensated or prior heart failure, history of cerebrovascular 
disease, diabetes mellitus and renal insufficiency) and surgical risk (high-risk defined as 
intrathoracic, intraperitoneal, or suprainguinal vascular surgery, or surgery involving 
large blood loss or fluid shifts) were defined according to the Cardiac Risk Stratification 
for Noncardiac Surgical Procedures of the 2007 guidelines on Perioperative 
Cardiovascular Evaluation and Care for Noncardiac Surgery of the American College of 
Cardiology/American Heart Association Task Force on Practice Guidelines. (16) 
 
Data for other preoperative clinical information regarding chronic obstructive 
pulmonary disease (COPD), hypertension and dyslipidemia were collected from routine 
clinical documentation entered into the institution’s perioperative clinical information 
system. 
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Residual neuromuscular block (RNMB) was defined as TOF<0.9 and it was quantified 
at admission to the PACU using acceleromyography of the adductor pollicis muscle 
(TOF-Watch®). (17, 18) 
 
For delirium screening, at PACU discharge and in the ward the next day after surgery, 
the nursing delirium screening scale were (Nu-DESC) (19) used, and patients with a 
Nu-DESC score of 2 or more points at least at one evaluation were considered delirium 
positive. Patients were tested for delirium by the research team at the time they were 
formally declared to be ‘ready for discharge’ to the regular ward by the physician in 
charge of the recovery room. In addition, the patients were seen on the morning of the 
first postoperative day. 
 
Postoperative respiratory complications 
Each postoperative ARE was defined on the data collection sheet using the following 
criteria according to the classification described by Murphy et al (20): upper airway 
obstruction requiring an intervention (jaw thrust, or oral or nasal airway); mild-
moderate hypoxia (Spo2 of 93%–90%) on 3 L nasal cannula O2 that was not improved 
after active interventions (increasing O2 flows to > 3 L/min, application of high-flow 
face mask O2, verbal requests to breathe deeply and tactile stimulation); severe hypoxia 
(Spo2 <90%) on 3 L nasal cannula O2 that was not improved after active interventions 
(increasing O2 flows to >3 L/min, application of high-flow facemask O2, verbal 
requests to breathe deeply, and tactile stimulation); signs of respiratory distress or 
impending ventilatory failure (respiratory rate >20 breaths per minute, accessory muscle 
use, and tracheal tug); Inability to breathe deeply when requested to by the PACU 
nurse; patient complaining of symptoms of respiratory or upper airway muscle 
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weakness (difficulty breathing, swallowing, or speaking); patient requiring reintubation 
in the PACU and Clinical evidence or suspicion of pulmonary aspiration after tracheal 
extubation (gastric contents observed in the oropharynx and hypoxemia). 
During the PACU stay the patients were observed continuously by the PACU nurses 
who contacted a study investigator without delay if a ARE was observed. The inability 
to breathe deeply and the assessement of symptoms of respiratory or upper airway 
muscle weakness were observed in intervals of 10 minutes. One other investigators of 
study then examined the patient to confirm that the patient met at least one of the 
criteria for an ARE. 
 
Statistical method   
Descriptive analysis of variables was used to summarize data. Ordinal and continuous 
data found not to follow a normal distribution, based on the Kolmogorov–Smirnov test 
for normality of the underlying population, are presented as median and interquartile 
range. Normally distributed data are presented as mean and standard deviation (SD). 
An univariate analysis was performed to identify differences between HR-OSA and LR-
OSA patients, using the Mann-Whitney U test to compare continuous variables and Chi-
square or Fisher’s exact test to compare proportions between 2 groups of subjects. 
Differences were considered statistically significant when P was <0.05. 
A univariate analysis was performed to identify predictors for ARE. Multiple regression 
binary logistic was used with forward conditional method in the model in order to 
identify independent predictors for ARE. In this model, all covariates with p<0.05 in the 
univariate analyses were entered and an odds ratio (OR) and 95% Confidence Interval 
(95% CI) were calculated.  
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Data was analyzed using SPSS software for Windows Version 19.0 (SPSS Inc., 
Chicago, IL, USA). 
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Results  
Form 256 patients consecutively admitted in the PACU during the study period, a total 
of 215 were studied.  
Forty-one patients were excluded: 12 patients were admitted to a surgical intensive care 
unit, 8 patients were unable to provide informed consent or had a MMSE <25, 2 patients 
did not undergo surgery, 2 patient underwent neurosurgery, 11 patient were less than 18 
years old, 3 patient did not speak Portuguese and 3 patient refused to participate.  
Of 215 patients include in the analysis (Table 1), 110 were classified as HR-OSA. 
These patients were older (median age 64 versus 43 years, p<0.001), had a higher BMI 
(median 27.7 versus 25.7, p<0.001), were more likely to be man (68% versus 48%, 
p<0.001), had a higher ASA physical status (ASA III, IV or V 32% versus 15%, 
p꞊0.004), and had higher RCRI scores (8% versus 0% for RCRI>2, p꞊0.002).  
Patients with HR-OSA showed a higher prevalence of pre-existing co-morbidities, 
including ischemic heart disease (15% versus 0%, p<0.001), congestive heart disease 
(5% versus 0%, p꞊0.017), diabetes with insulin therapy (25% versus 7%, p<0.001), 
hypertension (75% versus 21%, p<0.001), hyperlipidemia (55% versus 13%, p<0.001) 
and COPD (12% versus 3%, p꞊0.011).  
HR-OSA patient were submitted more frequently to intra-abdominal surgery (59% 
versus 37%, p꞊0.005) and less frequently to musculoskeletal (34% versus 49%, p꞊0.004) 
or head and neck surgery (7% versus 14%, p꞊0.002). HR-OSA patients were underwent 
more frequently loco regional anesthesia (23% versus 11%, p꞊0.049) and less frequently 
to general or combined anesthesia (77% versus 89%, p꞊0.049) and had hypothermia 
more frequently at PACU admission (36% versus 24%, p=0.045). HR-OSA patients had 
a longer LOS in the Hospital (median 7 versus 4 days, p꞊0.005).  
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Regarding respiratory complications (Table 2) that occurred in the PACU, patients with 
HR-OSA had more frequently ARE (24% versus 10%, p꞊0.011). HR-OSA patients had 
more frequently mild/moderated hypoxia (16% versus 6%, p꞊0.013) and a decreased 
inspiratory capacity (18% versus 5%, p꞊0.002).  
In a multivariate analyses occurrence (Table 3) and after adjustment for univariate 
predictor (age, hypertension, COPD and HR-OSA), only COPD was identified as an 
independent predictor of ARE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
Discussion  
In this study the incidence of patients with a STOP-BANG ≥3 were 51% what is a 
considerable and relevant figure for an incidence among patients undergoing elective 
surgery in our hospital.  
We relied on a STOP-BANG ≥3, since this has been demonstrated to have a very high 
sensitivity to screen patients with moderate/severe OSA. (12) Indeed recent systemic 
review by Abrishami et al. (21) showed that STOP-BANG questionnaire have a higher 
methodological quality and as Chung F et al. (12) suggest this cut-off may be adequate 
to stratify patients with unrecognized OSA in the surgical population at higher risk of 
postoperative complications. This author stated that this questionnaire is concise and 
simple to use and may help on the identification of HR-OSA patients.  
HR-OSA patients were more frequently males and as expected had a higher BMI 
(p<0.001) and were older (p<0.001). Similar results have been found by others (22, 23) 
and its importance is revealed by the inclusion of these variables in different tools used 
to access for OSA severity like sleep apnea clinical score (SACS) and even STOP-
BANG. 
The association between increased morbidity and untreated OSA is well established, 
which may result in an increased mortality rate (3, 24) and these patients are at an 
increased risk of developing cardiovascular disease. (25) In our study, we also realize 
that HR-OSA group had more frequently history of cardiac co-morbidities (ischemic 
heart disease and congestive heart disease), higher frequency of hypertension (22, 26-
28), hyperlipidaemia, diabetes (29) and also pulmonary chronic disease. This co-
morbidities may had although indirectly reflect a higher ASA physical status and higher 
RCRI scores in the HR-OSA patients.  
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Patients with HR-OSA were more frequently submitted to abdominal surgery, and loco 
regional anesthesia and had more frequently hypothermia. We may suppose that these 
three circumstances may be linked and may had influenced the simultaneous occurrence 
of each other. 
As well as was described in retrospective studies (5, 30, 31) our study revealed that HR-
OSA patients had also a  longer LOS in the Hospital. Liu S et al (31) suggests that 
postoperative hypoxemia may occur not only in the first postoperative  day and it was 
associated with adverse outcomes as frequent respiratory interventions, more need for 
intensive monitoring and a longer LOS in the Hospital.  In the other hand Rakesh G et 
al (5) suggest that a longer LOS in the Hospital was associated with coronary artery 
disease and metabolic syndrome.  
Patients with a STOP-BANG score ≥3 had also a higher incidence of RNMB. It is 
described that patients with a high BMI had a higher incidence of RNMB. (32) This fact 
has not yet been described for the patients with OSA, but our results suggest that 
enhanced monitoring is important in HR-OSA patients because they are exposed to 
additional risk for respiratory complications and the prevalence of patients with high 
BMI is higher in the HR-OSA patients. 
The incidence of postoperative respiratory complications was higher in patients who 
have STOP-BANG score ≥3. This is in agreement with other studies (5, 33) that found  
respiratory events to occur more frequently, particularly postoperative hypoxia that had 
a higher incidence in the patients at HR-OSA. However, in our study, as in the study of 
Chung et al (34) analysis of perioperative adverse events did not show significant 
respiratory morbidity in HR-OSA patients compared to the LR-OSA patients. In fact in 
our study we could not found that HR-OSA was a determinant for ARE.  
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This study has several limitations. The first and more important limitation is that it was 
not possible to compare the results of the STOP-BANG questionnaire with a definitive 
polysomnographic diagnosis. Second, our patients may have been at high risk for 
postoperative events without having OSA.  The use of the STOP-BANG score is used 
as an instrument to predict the risk of a patient to have OSA may have led to a high 
incidence of false positive results. It is possible that a higher score should have been 
used because recent studies had showed that the STOP-BANG score has a higher 
accuracy of detecting moderate to severe OSA patients in a surgical population when 
the score is greater than or equal to 5. (12) Third, the respiratory events were only 
registered in the PACU and complications that could have occurred after PACU 
discharge were not considered. This might be viewed as a major limitation since 
respiratory complications after surgery may be associated with adverse outcomes that 
occur during the hospital stay after PACU discharge. 
 
In conclusion the principal findings in our study were: 
 The incidence of HR-OSA patients was 51%; 
 HR-OSA patients had more co-morbidities as ischemic heart disease, congestive 
heart disease, use of insulin to treated diabetes, hypertension, hyperlipidemia 
and COPD; 
 HR-OSA patients have a higher incidence of postoperative respiratory 
complications, including mild/moderate hypoxia and decreased inspiratory 
capacity.  
 HR-OSA patients demonstrated a longer LOS in the Hospital.  
 HR-OSA was not an independent determinant for ARE.  
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Appendix: STOP-BANG Scoring Model 
1. Snoring. Do you snore loudly (louder than talking ou loud enough to be heard)? 
Yes  No 
2. Tired. Do you often feel tired, fatigued, or sleepy during daytime? 
Yes  No 
3. Observed. Has anyone observed you stop breathing during your sleep? 
Yes  No 
4. Blood pressure. Do you have or are you being treated for high blood pressure? 
Yes  No 
5. Body Mass Index. Body Mass Index more than 35 kg/m2? 
Yes  No 
6. Age. Age over 50 years old? 
Yes  No 
7. Neck circumference. Neck circumference greater than 40 cm? 
Yes  No 
8. Gender. Gender male? 
Yes  No 
 
 
 
High risk of Obstructive Sleep Apnea: answering yes to three or more items. 
Low risk of Obstructive Sleep Apnea: answering yes to less than three items.  
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Table 1. Patient baseline characteristics (n= 215) 
 
Variable 
      All 
      N=215 
HR-OSA 
N=110 
LR-OSA 
N=105 
p 
Age, median (IQR) 58 (43-68) 64 (58 – 72) 43 (33 – 57) <0.001(c) 
Gender, n (%)    <0.001
(a)
 
Male 125 (58) 75(68) 50 (48)  
Female 90 (42) 35(32) 55 (55)  
Site of Surgery, n (%)     
Intraabdominal 104 (48) 65 (59) 39 (37) 0.005
(a)
 
Musculoskeletal 88 (41) 37 (34) 51 (49) 0.004
(a)
 
Head and Neck 23 (11) 8 (7) 15 (14) 0.002
(a)
 
Body Mass Index (Kg/m
2
) 26.2 (23.6-30.0) 27.7 (24.4-32.1) 25.7(22.2 -28.1) <0.001
(c)
 
ASA physical status, n (%)    0.004
(a)
 
I/II 164 (76) 75 (68) 89 (85)  
III/IV/V 51 (24) 35 (32) 16 (15)  
High Risk surgery, n (%) 61 (28) 42 (38) 19 (18) 0.001
(a)
 
Ischemic heart disease, n (%) 17  (8) 17(15) 0 <0.001
(b)
 
Congestive heart disease, n (%) 6(3) 6 (5) 0 0.017
(b)
 
Cerebrovascular disease, n (%) 3(1) 3 (3) 0 0.132
(b)
 
Insulin therapy for diabetes, n (%) 35 (16) 28(25) 7(7) <0.001
(a)
 
Renal insufficiency, n, (%) 15 (7) 9 (8) 6(6) 0.478
(a)
 
RCRI, n (%)    0.002
(b)
 
RCRI≤2 206 (96) 101(92) 105 (100)  
RCRI>2 9 (4) 9 (8) 0  
Hypertension, n (%) 104 (48) 82 (75) 22(21) <0.001
(a)
 
Hyperlipidemia, n (%) 74 (34) 60 (55) 14 (13) <0.001
(a)
 
COPD, n (%) 16 (7) 13 (12) 3 (3) 0.011
(b)
 
Type of anesthesia, n (%)    0.049
(a)
 
Loco regional 36 (17) 25 (23) 11 (11)  
General / combined 179 (83) 85(77) 94(89)  
Magnitude of surgery, n (%)    0.170
(a)
 
Minor 18 (8) 11 (10) 7 (7)  
Medium 111(52) 50 (46) 61 (58)  
Major 86 (40) 49(45) 37 (35)  
Bariatric surgery, n (%) 8 (4) 6 (5) 2 (2) 0.156
(b)
 
Duration surgery, median (IQR) 90 (55 – 145) 90 (54-141) 90 (54-148) 0.849(c) 
Post-operative delirium hospital, n (%) 22 (10) 15 (14) 7 (7) 0.092
(a)
 
Temperature on admission, median (IQR) 35.5(34.9-36.0) 35.5(34.9-36.0) 35.5(35.1-36.0) 0.358
(c)
 
<35ºC, n (%) 65 (30) 40 (36) 25 (24) 0.045
(a)
 
Length of PACU stay (minutes), median (IQR) 112 (80-150) 118 (85-160) 105 (80-148) 0.081
(c)
 
Length of Hospital stay (days) 6 (3-12) 7 (5-17) 4 (2-8) 0.005
(c)
 
Perioperative muscle relaxant use, n (%) 132 (61) 61 (55) 71(65) 0.156
(a)
 
Neuromuscular residual blocking, n (%) 40 (30) 24 (22) 16(15) 0.021
(a)
 
 
a) Pearson's chi-squared test b) Fisher’s exact test c) Mann-Whitney U test 
IQR, Interquartil range 
HR-OSA, High-risk of OSA; ASA, American Society of Anesthesiologists; RCRI, Revised cardiac risk index; COPD, Chronic 
Pulmonary Obstructive Disease; PACU, Post Anesthesia Care Unit 
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Table 2. Respiratory complications (n= 215) 
Variable 
All 
(n=215) 
HR-OSA 
(n=110) 
LR-OSA 
(n=105) 
p 
     
Respiratory events 37 26 (24) 11 (10) 0.011 
Obstruction airway 3 1 (1) 2 (2) 0.534 
Hypoxia (mild/moderate) 24 18 (16) 6 (6) 0.013 
Hypoxia Severe 4 2 (2) 2 (2) 0.672 
Respiratory failure 4 2 (2) 2 (2) 0.672 
Inspiratory capacity decreased 25 20 (18) 5 (5) 0.002 
Muscle weakness 9 7 (6) 2 (2) 0.103 
Re-intubation 2 1 (1) 1 (1) 0.739 
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Table 3. Multivariate regression analysis for predictors of adverse respiratory events 
Variable Simple OR (95%CI) p *OR (95% CI) P
a
 
Age  1.0 (1.0 – 1.1) 0.046  - 
Hypertension 2.6 (1.2 – 5.5) 0.012  - 
COPD 4.4 (1.5– 12.7) 0.006 4.4 (1.5– 12.7) 0.006 
HR-OSA 2.7 (1.2 – 5.7) 0.013 - - 
 
a) Logistic regression analysis with forward conditional elimination method was used with an entry criterion of p < 
0.05. 
OR; Odds Ratio; CI, Confidence Interval 
COPD, Chronic Obstructive Pulmonary Disease; HR-OSA, High-Risk of Obstructive Sleep Apnea 
*Adjusted OR for age, hypertension, COPD and HR-OSA (variables considered to be determinants for adverse 
respiratory events in a univariate analyses). 
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Artwork Guideline Checklist (below). 
3. Upload each figure to Editorial Manager in conjunction with your manuscript text 
and tables. 
B) Digital Artwork Guideline Checklist 
Here are the basics to have in place before submitting your digital artwork: 
 Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. 
High resolution PDF files are also acceptable. 
 Crop out any white or black space surrounding the image. 
 Diagrams, drawings, graphs, and other line art must be vector or saved at a 
resolution of at least 1200 dpi. If created in an MS Office program, send the 
native (DOC, PPT, XLS) file. 
 Photographs, radiographs and other halftone images must be saved at a 
resolution of at least 300 dpi. 
 Photographs and radiographs with text must be saved as postscript or at a 
resolution of at least 600 dpi. 
 Each figure must be saved and submitted as a separate file. Figures should not 
be embedded in the manuscript text file. 
Remember: 
 References to figures should be made in order of appearance in the text and 
should be in Arabic numerals in parentheses, e.g. (Fig. 2). 
 Number figures in the figure legend in the order in which they are discussed. 
 Upload figures consecutively to the Editorial Manager web site and enter figure 
numbers consecutively in the Description field when uploading the files. 
 If hard copies are submitted they should have a label pasted to the back bearing 
the figure number, the title of the paper, the author’s name and a mark indicating 
the top of the figure. Figures should be presented to a width of 82 mm or, when 
the illustration demands it, to a width of 166 mm. 
 Photomicrographs must have internal scale markers. If photographs of people 
are used, their identities must be obscured or their written consent to use the 
photograph must have been obtained. If necessary the Editors may request 
copies of any consent forms. 
 If a figure has been published before, the original source must be acknowledged 
and written permission from the copyright holder for both print and electronic 
formats should be submitted with the material. Permission is required regardless 
of authorship or publisher, except for documents in the public domain. 
 Figures may be reduced, cropped or deleted at the discretion of the editor. 
 
Figure legends 
Captions should be typed in 1.5 spacing, beginning on a separate page. Each figure 
should be assigned an Arabic numeral, e.g. (Figure 3) and a brief title as a heading. 
Internal scales should be explained and staining methods for photomicrographs should 
be identified. 
 Units of measurement 
Scientific measurements should be given in SI units. Blood pressure, however, may be 
expressed in mmHg and haemoglobin as g dL-1. 
 
Abbreviations and symbols 
Authors are discouraged from using abbreviations. If an abbreviation is necessary please 
use only standard abbreviations. Avoid abbreviations in the title and abstract. The full 
term for which an abbreviation stands should precede its first use in the text unless it is 
a standard unit of measurement. 
 
Supplemental Digital Content 
Authors may submit supplemental digital content (SDC) to enhance their article’s text 
and to be considered for online-only posting. SDC may include the following types of 
content: text documents, graphs, tables, figures, graphics, illustrations, audio, and video. 
On the Attach Files page of the submission process, please select Supplemental Audio, 
Video, or Data for your uploaded file as the Submission Item. If an article with SDC is 
accepted, our production staff will create a URL with the SDC file. The URL will be 
placed in the call-out within the article. SDC files are not copy-edited by LWW staff, 
they will be presented digitally as submitted. For a list of all available file types and 
detailed instructions, please visit http://links.lww.com/A142. 
 
SDC Call-outs 
Supplemental Digital Content must be cited consecutively in the text of the submitted 
manuscript. Citations should include the type of material submitted (Audio, Figure, 
Table, etc.), be clearly labelled as "Supplemental Digital Content," include the 
sequential list number, and provide a description of the supplemental content. All 
descriptive text should be included in the call-out as it will not appear elsewhere in the 
article.  
For example:  
We performed many tests on the degrees of flexibility in the elbow (see Video, 
Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our 
results inconclusive. 
 
List of Supplemental Digital Content 
A listing of Supplemental Digital Content must be submitted at the end of the 
manuscript file. Include the SDC number and file type of the Supplemental Digital 
Content. This text will be removed by our production staff and not be published. 
For example: 
Supplemental Digital Content 1.wmv 
 
SDC File Requirements 
All acceptable file types are permissible up to 10 MBs. For audio or video files greater 
than 10 MBs, authors should first query the journal office for approval. For a list of all 
available file types and detailed instructions, please visit http://links.lww.com/A142. 
 
Reprints 
Reprints may be purchased using the appropriate form that will be made available with 
proofs. Orders should be sent when the proofs are returned; orders received after this 
time cannot be fulfilled. 
 
English language editing  
If you are inexperienced in publishing medical articles in English then it may be helpful 
to have your manuscript reviewed by a professional editor so that you submit it in 
grammatically and syntactically acceptable English. The list below is provided for the 
benefit of authors seeking assistance in writing and editing their manuscripts. The EJA 
does not endorse any writing/editing services. 
American Journal Experts (http://www.journalexperts.com/?rcode=LWW1 Discount 
Available for LWW Journal Authors)  BioMedES (Biomedical Editorial Services) 
(http://www.biomedes.co.uk)  
Biomedical Science Writers, LLC 
(http://www.biomedicalsciencewriters.com/index.htm)  
BoldFace Editors (http://www.boldfaceeditors.com)  
Cambridge Language Consultants (http://www.camlang.com/proof.cfm)  
Council of Science Editors Manuscript Services Listing 
(http://www.councilscienceeditors.org)  
Editage (http://www.editage.com)  
Elizabeth Betsch, ELS , Medical Edits.com (ejb@medicaledits.com)  
English Science Editing (http://www.english-science.com/journals.html)  
English Manager Science Editing (Australia) (http://www.sciencemanager.com/)  
ScienceDocs (http://www.sciencedocs.com)  
SciTechEdit International Science Editing 
(http://www.internationalscienceediting.com/)  
SquirrelScribe (http://www.squirrelscribe.com)  
Text Check (http://www.textcheck.com)  
The Medical Editor (http://www.themedicaleditor.com/)  
Write Science Right (http://writescienceright.com) 
 
